Xilio Therapeutics Inc. (XLO)
NASDAQ: XLOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
XLO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $59.29M
- EPS (TTM)
- -$0.60
- Dividend yield
- None
- 52-week range
- 6.47 – 12.59
- Day range
- 9.01 – 9.01
- Volume / Avg
- 922 / 20.06K
- Beta
- —
- Shares outstanding
- 6.58M
52-week range
XLO stock today
Shares of Xilio Therapeutics (XLO) finished higher on Oct 7 at $9.01, a gain of 0.11% or $0.01 per share, versus the S&P 500's 0.22% decline. Trading was light, with 922 shares changing hands, about 5% of the average daily volume. Shares are 28.4% below their 52-week high of $12.59, set on Oct 30, 2025 and 39.3% above the 52-week low of $6.47, in the middle of the past year's range.
XLO is up 0.6% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 21.7%. Xilio Therapeutics has posted a net loss over the last twelve months (EPS of -$0.60), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Xilio Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2021
Xilio Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CNTBConnect Biopharma Holdings Limited | 0.9447 | +4.34% | $59.49M | vs XLO |
| BOLDBoundless Bio Inc. | 2.64 | +2.72% | $60.05M | vs XLO |
| ATHEAlterity Therapeutics Limited ADR | 3.32 | -1.48% | $60.45M | vs XLO |
| ACETAdicet Bio Inc. | 6.18 | -1.12% | $57.85M | vs XLO |
| ALDXAldeyra Therapeutics Inc. | 0.9586 | +4.66% | $57.83M | vs XLO |
| PLRXPliant Therapeutics Inc. | 0.99 | -3.88% | $61.30M | vs XLO |
| RNXTRenovoRx Inc. | 1.37 | -1.44% | $61.83M | vs XLO |
| MREOMereo BioPharma Group plc ADR | 0.3528 | +0.77% | $56.34M | vs XLO |
Indexes, lists and sector
Xilio Therapeutics stock FAQ
What is Xilio Therapeutics's stock price today?
XLO last traded at $9.01 as of Oct 7, 4:00 PM EDT, up 0.11% on the day. Prices are delayed at least 15 minutes.
Does Xilio Therapeutics pay a dividend?
No. Xilio Therapeutics does not currently pay a regular cash dividend.
Has XLO ever split its stock?
Yes. The most recent XLO stock split was a 1-for-14 split on Mar 16, 2026.
What is the XLO 52-week high?
The 52-week high for XLO is $12.59 and the 52-week low is $6.47. The stock is currently 28.4% below its high.